CD8A and neoplasm: A recent study suggested that a high frequency of PD-L1+ CD4+ CD25+ Tregs in the tumor microenvironment could increase the number of PD-1+ CD8 Tregs and induce a more lethal effect of TILs by PD/PD-L1 blockade therapy [29].